Stock RGIN REGENICIN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Regenicin, Inc.

Equities

RGIN

US75887Q1022

Delayed OTC Markets
Other stock markets
 18:26:13 13/05/2024 BST 		5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Regenicin, Inc. -.--% +9,900.00%
2023 Regenicin, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
2023 Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REGENICIN, INC. Stock Regenicin, Inc.
 15.35K - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.82B -
ARGENX SE Stock argenx SE
 22.48B -
GENMAB A/S Stock Genmab A/S
 18.32B
  1. Stock Market
  2. Equities
  3. RGIN Stock
  4. Charts Regenicin, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW